Affordable Access

deepdyve-link
Publisher Website

Coronavirus Disease 2019 Vaccine Development: An Overview.

Authors
  • Sumirtanurdin, Riyadi1, 2
  • Barliana, Melisa Intan2, 3
  • 1 Pharmacist Profession Education, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia. , (Indonesia)
  • 2 Biotechnology Pharmacy Laboratory, Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia. , (Indonesia)
  • 3 Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia. , (Indonesia)
Type
Published Article
Journal
Viral Immunology
Publisher
Mary Ann Liebert
Publication Date
Apr 01, 2021
Volume
34
Issue
3
Pages
134–144
Identifiers
DOI: 10.1089/vim.2020.0119
PMID: 32985963
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

To this day, the coronavirus disease 2019 (COVID-19) pandemic has not shown signs of abating. Moreover, the virus responsible for the pandemic, severe acute respiratory syndrome coronavirus 2, has evolved into three different variants. This phenomenon highlights an even greater need to develop drugs and vaccines to control the rate of infection and spread of the disease. As of July 7, 2020, at least 160 vaccine candidates, 21 of which have entered the clinical trial phase, have been developed. This article describes the latest advances in development, reliable platforms, strategies used, and challenges that remain in developing COVID-19 vaccines.

Report this publication

Statistics

Seen <100 times